Elisa did her Master’s in Clinical Microbiology at the Microbiology Department in Germans Trias i Pujol University Hospital, within Germans Trias i Pujol Research Institute (IGTP), Barcelona, Spain. Then, she was guest researcher at the Centers for Disease Control and Prevention (CDC) in Atlanta, USA, where she undertook the experimental part of her PhD from 2001 to 2003. Afterwards, she completed her predoctoral training at the Center of Epidemiological Studies on HIV/STIs in Catalonia (CEEISCAT), and defended her doctoral thesis in 2005, for which she received two awards. Back at the Microbiology Department in Germans Trias i Pujol Hospital, Dr. Martró started a research line on hepatitis C virus in 2006 as a postdoc, and then as a principal investigator since 2010, when she entered the Miguel Servet programme funded by the Spanish Government. Since then, Dr. Martró leads the research group on Clinical Virology and New Diagnostic Approaches at IGTP. The research focus of her group was originally the study of HCV genetic variability and its clinical applications in personalized medicine, and the characterization of HCV molecular epidemiology. Dr. Martro’s current research is focussed on improving HCV diagnosis in vulnerable groups (MSM, sex workers, PWIDs and migrants) in the community setting through novel molecular assays and screening strategies. Her work characterising the local HCV epidemics in these collectives has led her to participate in the Commission for the elaboration of the “Plan for the Prevention and Control of hepatitis C in Catalonia”. She is also a member of Group 27 of CIBER in Epidemiology and Public Health (CIBERESP) of Instituto de Salud Carlos III and of the Clinical Microbiology.